HeyJaredAdria Cimino
- Indexed articles, last 90 days
- 53
- Latest publication
- Sep 30, 2026
- Outlet visibility, for Aol
- Top 5K sites
- Earliest in this view
- Aug 27, 2026
Latest articles
Prediction: Moderna Stock Will Soar 100% by 2030 - AOL (opens the original)
Read excerpt
Moderna was known for its coronavirus vaccine a few years ago, but it’s greatly expanded its pipeline in recent years. Investors, recognizing the growth potential, piled into the stock this year, and it’s heading for a gain of more than 500%. Moderna(NASDAQ: MRNA) delivered an enormous win for investors during the early days of the pandemic thanks to its leadership in the coronavirus vaccine market. But when demand for the vaccine, at the time the biotech's only commercialized product, declined,
SpaceX's Pullback From $225 Sets Up a Classic Buy the Dip Case for Long-Term Investors - AOL (opens the original)
Read excerpt
SpaceX offers investors the opportunity to get in on three high-growth areas: space, connectivity, and AI. The company recently completed the world’s biggest IPO ever. 10 stocks we like better than Space Exploration Technologies › Space Exploration Technologies(NASDAQ: SPCX), better known as SpaceX, has been one of the most-watched companies of the year. A few months ago, and after much anticipation, the tech and industrial giant launched the biggest-ever initial public offering, raising $85 bil
The Big Short’s Michael Burry Delivers His Bluntest Warning Yet Regarding AI Stocks. Should You Listen? - AOL (opens the original)
Read excerpt
AI stocks have soared in recent years, leading gains in the S&P 500. Burry has been betting against the sector, with short positions in some of the industry’s biggest names. 10 stocks we like better than S&P 500 Index › The S&P 500 has climbed for the past three calendar years, and in spite of various headwinds this year, it's continued to trek higher. Leading this march are companies that play a major role in the artificial intelligence (AI) space. And investors have generally been piling in, w
2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right. - AOL (opens the original)
Read excerpt
Vertex Pharmaceuticals is the leader in the cystic fibrosis market and has the intellectual property to maintain this dominance. The company has expanded into additional treatment areas and is awaiting a regulatory decision for another potential new product in the coming weeks. 10 stocks we like better than Vertex Pharmaceuticals › Vertex Pharmaceuticals(NASDAQ: VRTX) has been a clear winner for investors over time. Earnings and stock performance have progressed steadily thanks to the company's
Not the GPUs. This Overlooked Piece of Nvidia's Business Could Matter Most for the Stock's Next Leg Up. - AOL (opens the original)
Read excerpt
Nvidia has seen revenue soar in the triple digits thanks to its strength in the GPU market. The company dominates this space and is seeking to do the same in another area that may be key in AI. Nvidia(NASDAQ: NVDA) has built an artificial intelligence (AI) empire thanks to its strength in one particular area: the graphics processing unit (GPU). These powerful chips have been the crucial tool that's fueled the development and use of AI so far. Researchers and companies use the GPU for key tasks s
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5K sites
For Aol, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.